Santolla et al. [39] firstly demonstrated that GPER was implicated in the modulation of fatty acid synthase (FASN) in cancer cells and CAFs, thus regulating neoplastic transformation of the colon through the EGFR/ERK/c-Fos/activating protein1 (AP1) signaling pathway. This evidence concerns the gene FOS and cancer.